Evidence map›Paper›PMID 31498617›Full record

ArticleJournal of medicinal chemistry2019

Discovery of Benzamidine- and 1-Aminoisoquinoline-Based Human MAS-Related G-Protein-Coupled Receptor X1 (MRGPRX1) Agonists.

Eva Prchalová, Niyada Hin, Ajit G Thomas, Vijayabhaskar Veeravalli, Justin Ng, Jesse Alt, Rana Rais, Camilo Rojas, Zhe Li, Hiroe Hihara and 10 more

Open access · greenAbstract read
In one paragraph

Article in Journal of medicinal chemistry, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 31 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. The structure, function, and pharmacology of MRGPRs.Trends in pharmacological sciences · 2023
    Review
  5. Article
  6. Article
  7. Thieno[2,3-Journal of medicinal chemistry · 2022
    Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 4 institutions in 2 countries.

Eva Prchalová
Niyada Hin
Ajit G Thomas
Vijayabhaskar Veeravalli
Justin Ng
Jesse Alt
Camilo Rojas
Zhe Li
Hiroe HiharaTsukuba Research Laboratories , Eisai Co., Ltd. , Tsukuba , Ibaraki 300-2635 , Japan.
Mika AokiTsukuba Research Laboratories , Eisai Co., Ltd. , Tsukuba , Ibaraki 300-2635 , Japan.
Kyoko YoshizawaTsukuba Research Laboratories , Eisai Co., Ltd. , Tsukuba , Ibaraki 300-2635 , Japan.
Tomoki NishiokaTsukuba Research Laboratories , Eisai Co., Ltd. , Tsukuba , Ibaraki 300-2635 , Japan.
Shuichi SuzukiTsukuba Research Laboratories , Eisai Co., Ltd. , Tsukuba , Ibaraki 300-2635 , Japan.
Theresa KopajticBiobehavioral Imaging and Molecular Neuropsychopharmacology Unit , National Institute on Drug Abuse-Intramural Research Program, National Institutes of Health , Baltimore , Maryland 21224 , United States.
Sheena ChatrathDepartment of Anesthesiology and Center for the Study of Itch , Washington University School of Medicine , St. Louis , Missouri 63110 , United States.
Qin LiuDepartment of Anesthesiology and Center for the Study of Itch , Washington University School of Medicine , St. Louis , Missouri 63110 , United States.
Xinzhong Dong
Barbara S SlusherORCID 0000-0001-9814-4157
Takashi TsukamotoORCID 0000-0002-0216-7520
Johns Hopkins University · USEisai (Japan) · JPWashington University in St. Louis · USNational Institutes of Health · US

Funding

Institute for Clinical and Translational ResearchUL1TR001079 · NCATS · JOHNS HOPKINS UNIVERSITY · PI FORD, DANIEL ERNEST · 2013 to 2017
$60.1M
Functional analysis of the Mrg receptor family in pain sensationR01NS054791 · NINDS · JOHNS HOPKINS UNIVERSITY · PI DONG, XINZHONG · 2007 to 2020
$5.0M
Positive allosteric modulators of MrgX1 for the treatment of chronic painR21NS101954 · NINDS · JOHNS HOPKINS UNIVERSITY · PI TSUKAMOTO, TAKASHI · 2017 to 2018
$450k
NCATS NIH HHS UL1 TR001079NINDS NIH HHS R01 NS054791NINDS NIH HHS R21 NS101954
6 · The paper itself

Abstract

Mas-related G-protein-coupled receptor X1 (MRGPRX1) is a human sensory neuron-specific receptor and has been actively investigated as a therapeutic target for the treatment of pain. By use of two HTS screening hit compounds, 4-(4-(benzyloxy)-3-methoxybenzylamino)benzimidamide (

Indexed as

AnalgesicsAnimalsBenzamidinesChronic PainDrug DesignHEK293 CellsHumansIsoquinolinesMagnetic Resonance SpectroscopyMaleMiceNeuronsReceptors, G-Protein-Coupled1-aminoisoquinolineAnalgesicsBenzamidinesIsoquinolinesmas-related gene-X1 receptor, humanMrgprx1 protein, mouseReceptors, G-Protein-Coupled

Identifiers

PMID31498617
PMCPMC10079166
OpenAlexW2972348580

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.